Megan Hauptman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Megan Hauptman has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Mio Nakamura
Department of Dermatology, University of Michigan, Ann Arbor, MI, USA
5 shared publications - Joseph S. Durgin
Department of Pathology University of Michigan Ann Arbor Michigan USA
3 shared publications Mio Nakamura
Department of Dermatology, University of Michigan, Ann Arbor, MI, USA
3 shared publications- Albert Yang
Department of Dermatology, University of Michigan, 1500 E Medical Center Dr, Ann Arbor, MI, 48105, United States, 1 734-936-4054
2 shared publications - Allison C. Billi
Department of Dermatology, University of Michigan, Ann Arbor, MI, USA
2 shared publications - Jungsoo Chang
Department of Dermatology, University of Michigan, Ann Arbor, Michigan
2 shared publications
Latest Publications
- Open Access
- 11 May 2026
- Published by Dermsquared in SKIN The Journal of Cutaneous Medicine
- Vol. 10 (3) , 3072-3081
Patient Characteristics and Treatment Approaches in Delusional Infestation Across Two Medical Centers: A Retrospective Study
Background: Delusional Infestation (DI) is a psychiatric disorder marked by persistent, false belief of infestation despite medical evidence to the contrary. Large-scale research on DI is limited, with only one population-based study to date. DI remains poorly understood and difficult to manage. Methods: We conducted a multicenter retrospective chart review of adult outpatients seen in tertiary dermatology clinics at the University of Michigan and University of California, San Francisco between January 2021 and May 2024. Patients were identified using relevant ICD codes, and eligibility was confirmed by manual review for DSM-5 criteria for DI. Key clinical and demographic data were extracted, and relevant risk was calculated using national prevalence data from NAMI and SAMHSA. Results: We identified 155 patients with DI; most were female (79%), non-Hispanic (94%), and white (73%). Mean age of onset was 54 years, with a three-year diagnostic delay. Delusions commonly involved parasites (25%) or bugs/insects (27%). Diagnostic evaluations included skin biopsy (34%) and skin scrapings (15%), with significant variation between centers. Substance use and psychiatric comorbidities were prevalent, with elevated relative risks compared to population data. Treatments most often involved antiparasitic agents, pimozide, or second-generation antipsychotics; pimozide was associated with the highest rate of improvement Conclusions: DI primarily affects middle-aged female and is marked by delayed diagnosis, frequent substance use, and psychiatric comorbidities. Despite varied diagnostic approaches, treatment outcomes remain poor. Multidisciplinary care and standardized protocols are needed to improve management and outcomes.
- 11 May 2026
- Published by Dermsquared in SKIN The Journal of Cutaneous Medicine
- Vol. 10 (3) , 3072-3081
Open AccessPatient Characteristics and Treatment Approaches in Delusional Infestation Across Two Medical Centers: A Retrospective Study
Background: Delusional Infestation (DI) is a psychiatric disorder marked by persistent, false belief of infestation despite medical evidence to the contrary. Large-scale research on DI is limited, with only one population-based study to date. DI remains poorly understood and difficult to manage. Methods: We conducted a multicenter retrospective chart review of adult outpatients seen in tertiary dermatology clinics at the University of Michigan and University of California, San Francisco between January 2021 and May 2024. Patients were identified using relevant ICD codes, and eligibility was confirmed by manual review for DSM-5 criteria for DI. Key clinical and demographic data were extracted, and relevant risk was calculated using national prevalence data from NAMI and SAMHSA. Results: We identified 155 patients with DI; most were female (79%), non-Hispanic (94%), and white (73%). Mean age of onset was 54 years, with a three-year diagnostic delay. Delusions commonly involved parasites (25%) or bugs/insects (27%). Diagnostic evaluations included skin biopsy (34%) and skin scrapings (15%), with significant variation between centers. Substance use and psychiatric comorbidities were prevalent, with elevated relative risks compared to population data. Treatments most often involved antiparasitic agents, pimozide, or second-generation antipsychotics; pimozide was associated with the highest rate of improvement Conclusions: DI primarily affects middle-aged female and is marked by delayed diagnosis, frequent substance use, and psychiatric comorbidities. Despite varied diagnostic approaches, treatment outcomes remain poor. Multidisciplinary care and standardized protocols are needed to improve management and outcomes.
- 3 May 2026
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
A Cohort-Based Study of Patients With Delusional Infestation: Characterizing the Patient Population
Background: Delusional infestation (DI) is a rare psychodermatologic disorder in which the exact epidemiologic data and effective management strategies are not yet well understood. Objective: To investigate a recent cohort of DI patients to understand current trends in patient characteristics, presentation, and management of DI. Methods: A retrospective chart review of patients with DI seen at the University of Michigan tertiary care dermatology clinics was performed between January 2021 and May 2024. We included patients who met Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition diagnostic criteria for DI who reported at least 1 complaint of living or nonliving delusions for at least 1 month. Results: We identified 81 DI patients (incidence 59.5/100 000 person-years; 84% female). Mean symptom onset was age 51.5, with a 3-year mean diagnostic delay. Most reported living delusions were notably parasites (24%) and bugs (22%). Common diagnostics were punch biopsies (35%) and mineral oil prep (15%). Depression (58%), anxiety (53%), and substance use (35%) were frequent, but only 31% formally saw psychiatry. Topical or oral antiparasitics were used in 58% (26% improved); second-generation antipsychotics in 31% (12% improved); first-generation antipsychotics (eg, pimozide) in 21% (18% improved). Pharmacotherapy response rates were modest; relapse rates were unclear. Conclusion: We report a 2-fold increase in the incidence of DI and significant female predominance in our study population. The majority of patients experience symptoms of living infestation, with non-specific “bugs” or “parasites” being the most common delusion.
- 3 May 2026
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
A Cohort-Based Study of Patients With Delusional Infestation: Characterizing the Patient Population
Background: Delusional infestation (DI) is a rare psychodermatologic disorder in which the exact epidemiologic data and effective management strategies are not yet well understood. Objective: To investigate a recent cohort of DI patients to understand current trends in patient characteristics, presentation, and management of DI. Methods: A retrospective chart review of patients with DI seen at the University of Michigan tertiary care dermatology clinics was performed between January 2021 and May 2024. We included patients who met Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition diagnostic criteria for DI who reported at least 1 complaint of living or nonliving delusions for at least 1 month. Results: We identified 81 DI patients (incidence 59.5/100 000 person-years; 84% female). Mean symptom onset was age 51.5, with a 3-year mean diagnostic delay. Most reported living delusions were notably parasites (24%) and bugs (22%). Common diagnostics were punch biopsies (35%) and mineral oil prep (15%). Depression (58%), anxiety (53%), and substance use (35%) were frequent, but only 31% formally saw psychiatry. Topical or oral antiparasitics were used in 58% (26% improved); second-generation antipsychotics in 31% (12% improved); first-generation antipsychotics (eg, pimozide) in 21% (18% improved). Pharmacotherapy response rates were modest; relapse rates were unclear. Conclusion: We report a 2-fold increase in the incidence of DI and significant female predominance in our study population. The majority of patients experience symptoms of living infestation, with non-specific “bugs” or “parasites” being the most common delusion.
- Open Access
- 1 May 2026
- Published by Taylor & Francis in Psoriasis: Targets and Therapy
- Vol. ume 16, 1-4
Paraneoplastic Papuloerythroderma of Ofuji Masquerading as Worsening Psoriasis
Paraneoplastic papuloerythroderma of Ofuji (PEO) is a rare cause of exfoliative erythroderma characterized by intensely pruritic, generalized erythema and scale with relative sparing of the skin folds (deck-chair sign) and is frequently associated with underlying malignancy, most commonly cutaneous T-cell lymphoma (CTCL). We present a unique case of paraneoplastic PEO in a patient with a history of plaque psoriasis whose rash suddenly began to worsen despite treatments for psoriasis. He developed diffuse brightly erythematous plaques with sparing fo the skin folds and hyperkeratotic, fissured plaques on the palms and soles. This ultimately led to hospitalization for erythroderma. Upon further work up, he was found to have squamous cell carcinoma of the lung by computed tomography. This case underscores that abrupt erythrodermic worsening in a patient with known psoriasis should prompt evaluation for an underlying paraneoplastic process rather than being attributed to psoriasis progression alone.
- 1 May 2026
- Published by Taylor & Francis in Psoriasis: Targets and Therapy
- Vol. ume 16, 1-4
Open AccessParaneoplastic Papuloerythroderma of Ofuji Masquerading as Worsening Psoriasis
Paraneoplastic papuloerythroderma of Ofuji (PEO) is a rare cause of exfoliative erythroderma characterized by intensely pruritic, generalized erythema and scale with relative sparing of the skin folds (deck-chair sign) and is frequently associated with underlying malignancy, most commonly cutaneous T-cell lymphoma (CTCL). We present a unique case of paraneoplastic PEO in a patient with a history of plaque psoriasis whose rash suddenly began to worsen despite treatments for psoriasis. He developed diffuse brightly erythematous plaques with sparing fo the skin folds and hyperkeratotic, fissured plaques on the palms and soles. This ultimately led to hospitalization for erythroderma. Upon further work up, he was found to have squamous cell carcinoma of the lung by computed tomography. This case underscores that abrupt erythrodermic worsening in a patient with known psoriasis should prompt evaluation for an underlying paraneoplastic process rather than being attributed to psoriasis progression alone.
- Open Access
- 12 January 2026
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 9, e76674
Leveraging AI Large Language Models for Writing Clinical Trial Proposals in Dermatology: Instrument Validation Study
Background: Large language models (LLMs) are becoming increasingly popular in clinical trial design but have been underused in research proposal development. Objective: This study compared the performance of commonly used open access LLMs versus human proposal composition and review. Methods: A total of 10 LLMs were prompted to write a research proposal. Six physicians and each of the LLMs assessed 11 blinded proposals for capabilities and limitations in accuracy and comprehensiveness. Results: ChatGPT-o1 and Llama 3.1 were rated the most and least accurate, respectively, by human scorers. LLM scorers rated ChatGPT-o1 and DeepSeek R1 as the most accurate. ChatGPT-o1 and Llama 3.1 were rated as the most and least comprehensive, respectively, by human and LLM scorers. LLMs performed poorly on scoring proposals and, on average, rated proposals 1.9 points higher than humans for both accuracy and comprehensiveness. Conclusions: Paid versions of ChatGPT remain the highest-quality and most versatile option of the available LLMs. These tools cannot replace expert input but serve as powerful assistants, streamlining the development process and enhancing productivity.
- 12 January 2026
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 9, e76674
Open AccessLeveraging AI Large Language Models for Writing Clinical Trial Proposals in Dermatology: Instrument Validation Study
Background: Large language models (LLMs) are becoming increasingly popular in clinical trial design but have been underused in research proposal development. Objective: This study compared the performance of commonly used open access LLMs versus human proposal composition and review. Methods: A total of 10 LLMs were prompted to write a research proposal. Six physicians and each of the LLMs assessed 11 blinded proposals for capabilities and limitations in accuracy and comprehensiveness. Results: ChatGPT-o1 and Llama 3.1 were rated the most and least accurate, respectively, by human scorers. LLM scorers rated ChatGPT-o1 and DeepSeek R1 as the most accurate. ChatGPT-o1 and Llama 3.1 were rated as the most and least comprehensive, respectively, by human and LLM scorers. LLMs performed poorly on scoring proposals and, on average, rated proposals 1.9 points higher than humans for both accuracy and comprehensiveness. Conclusions: Paid versions of ChatGPT remain the highest-quality and most versatile option of the available LLMs. These tools cannot replace expert input but serve as powerful assistants, streamlining the development process and enhancing productivity.
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Dermatological Medicine
- Vol. 2026 (1) , 6524620
Leukemia Cutis Exhibiting the Koebner Phenomenon: A Rare Clinical Presentation of Acute Myeloid Leukemia
Leukemia cutis with predilection for sites of prior cutaneous trauma, often described as a Koebner‐like phenomenon, is a rare but recognized occurrence. We present a unique case of an, otherwise, healthy male who developed leukemia cutis at a prior unrelated biopsy site, leading to a new diagnosis of acute myeloid leukemia (AML). Certain AML subtypes with extramedullary propensity, particularly M4 and M5, as seen in our patient, are associated with an increased risk of leukemia cutis. Unlike their medullary counterparts, extramedullary AML cells preferentially migrate to and persist in tissues outside the bone marrow, where the local microenvironment may promote immune escape. Although the localization of leukemia cutis to the biopsy site is consistent with a Koebner‐like response, it remains uncertain whether subclinical leukemic cells were already present at the time of the initial excision; therefore, a definitive causal relationship between trauma and leukemic infiltration cannot be established. Additionally, the prior keratoacanthoma and its excision may have created a localized immunocompromised cutaneous district, or locus minoris resistentiae , further predisposing the site to leukemic cell infiltration. The immunologic features of extramedullary AML, including impaired antigen presentation and T‐cell exhaustion, overlap with this concept of localized immune dysregulation and may have facilitated site‐specific leukemic infiltration. New infiltrative plaques at sites of prior skin trauma or biopsy warrant prompt biopsy and histopathological evaluation, even in patients without known hematologic malignancy. Leukemia cutis may represent the first manifestation of underlying acute leukemia, making early recognition critical for timely oncologic referral and treatment.
- 1 January 2026
- Published by Wiley in Case Reports in Dermatological Medicine
- Vol. 2026 (1) , 6524620
Open AccessLeukemia Cutis Exhibiting the Koebner Phenomenon: A Rare Clinical Presentation of Acute Myeloid Leukemia
Leukemia cutis with predilection for sites of prior cutaneous trauma, often described as a Koebner‐like phenomenon, is a rare but recognized occurrence. We present a unique case of an, otherwise, healthy male who developed leukemia cutis at a prior unrelated biopsy site, leading to a new diagnosis of acute myeloid leukemia (AML). Certain AML subtypes with extramedullary propensity, particularly M4 and M5, as seen in our patient, are associated with an increased risk of leukemia cutis. Unlike their medullary counterparts, extramedullary AML cells preferentially migrate to and persist in tissues outside the bone marrow, where the local microenvironment may promote immune escape. Although the localization of leukemia cutis to the biopsy site is consistent with a Koebner‐like response, it remains uncertain whether subclinical leukemic cells were already present at the time of the initial excision; therefore, a definitive causal relationship between trauma and leukemic infiltration cannot be established. Additionally, the prior keratoacanthoma and its excision may have created a localized immunocompromised cutaneous district, or locus minoris resistentiae , further predisposing the site to leukemic cell infiltration. The immunologic features of extramedullary AML, including impaired antigen presentation and T‐cell exhaustion, overlap with this concept of localized immune dysregulation and may have facilitated site‐specific leukemic infiltration. New infiltrative plaques at sites of prior skin trauma or biopsy warrant prompt biopsy and histopathological evaluation, even in patients without known hematologic malignancy. Leukemia cutis may represent the first manifestation of underlying acute leukemia, making early recognition critical for timely oncologic referral and treatment.
- Open Access
- 4 September 2025
- Published by Wiley in Photodermatology, Photoimmunology & Photomedicine
- Vol. 41 (5) , e70051
Narrowband‐Ultraviolet B Phototherapy for Psoriasis Treatment in Skin of Color: A Systematic Review and Meta‐Analysis
Background: Narrowband‐ultraviolet B (NB‐UVB) phototherapy is an effective treatment for psoriasis in patients who have failed topical regimens or those who desire to avoid systemic treatment. Despite its regular use in non‐white individuals, NB‐UVB treatment response for psoriasis in skin of color (SOC) has not been systematically reviewed. Methods: We conducted a systematic review on the basis of the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) on all available studies to date assessing NB‐UVB for psoriasis treatment in skin of color (SOC) (up to 15 November 2024). The primary outcome was qualitative data on clinical outcomes of UVB (PASI 75). Random‐effects meta‐analysis was performed to assess treatment responses. Secondary outcomes of biochemical and immunologic mechanisms of NB‐UVB, NB‐UVB in combination with other treatments, and NB‐UVB compared to other forms of phototherapy were assessed. Results: Of 1283 articles initially identified, 54 were ultimately included for formal review. We identified 43 articles assessing clinical outcomes of NB‐UVB phototherapy in patients with Fitzpatrick skin type III–IV for a total of 1322 patients with chronic plaque psoriasis and 12 patients with palmoplantar psoriasis. Nine studies were included for meta‐analysis of PASI75 response; 70.5% of patients achieved PASI75, and all studies demonstrated statistically significant PASI improvement after treatment. NB‐UVB demonstrated a higher rate of complete clearance when compared to BB‐UVB but did not result in a statistically significant difference in the proportion of the patient population achieving PASI75 when compared to PUVA. Conclusions: Phototherapy is effective for the treatment of psoriasis in SOC patients and remains a valuable treatment option despite the advent of various topical, systemic, and biologic treatments for psoriasis.
- 4 September 2025
- Published by Wiley in Photodermatology, Photoimmunology & Photomedicine
- Vol. 41 (5) , e70051
Open AccessNarrowband‐Ultraviolet B Phototherapy for Psoriasis Treatment in Skin of Color: A Systematic Review and Meta‐Analysis
Background: Narrowband‐ultraviolet B (NB‐UVB) phototherapy is an effective treatment for psoriasis in patients who have failed topical regimens or those who desire to avoid systemic treatment. Despite its regular use in non‐white individuals, NB‐UVB treatment response for psoriasis in skin of color (SOC) has not been systematically reviewed. Methods: We conducted a systematic review on the basis of the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) on all available studies to date assessing NB‐UVB for psoriasis treatment in skin of color (SOC) (up to 15 November 2024). The primary outcome was qualitative data on clinical outcomes of UVB (PASI 75). Random‐effects meta‐analysis was performed to assess treatment responses. Secondary outcomes of biochemical and immunologic mechanisms of NB‐UVB, NB‐UVB in combination with other treatments, and NB‐UVB compared to other forms of phototherapy were assessed. Results: Of 1283 articles initially identified, 54 were ultimately included for formal review. We identified 43 articles assessing clinical outcomes of NB‐UVB phototherapy in patients with Fitzpatrick skin type III–IV for a total of 1322 patients with chronic plaque psoriasis and 12 patients with palmoplantar psoriasis. Nine studies were included for meta‐analysis of PASI75 response; 70.5% of patients achieved PASI75, and all studies demonstrated statistically significant PASI improvement after treatment. NB‐UVB demonstrated a higher rate of complete clearance when compared to BB‐UVB but did not result in a statistically significant difference in the proportion of the patient population achieving PASI75 when compared to PUVA. Conclusions: Phototherapy is effective for the treatment of psoriasis in SOC patients and remains a valuable treatment option despite the advent of various topical, systemic, and biologic treatments for psoriasis.
- Open Access
- 28 August 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Leveraging Artificial Intelligence Large Language Models for Writing Clinical Trial Proposals in Dermatology (Preprint)
BACKGROUND Large language models (LLMs) are becoming increasingly popular in clinical trial design but have been underutilized in research proposal development. OBJECTIVE This study compares the performance of commonly used open access LLMs versus human proposal composition and review. METHODS Ten LLMs were prompted to write a research proposal. Six physicians and each of the LLMs assessed 11 blinded proposals for capabilities and limitations in accuracy and comprehensiveness. RESULTS Chat GPT o1 was rated the most accurate and LLaMA 3.1 the least accurate by human scorers. LLM scorers rated Chat GPT o1 and Deepseek R1 the most accurate. Chat GPT o1 was the most comprehensive and LLaMA 3.1 the least comprehensive by human and LLM scorers. LLMs performed poorly on scoring proposals, and on average rated proposals 1.9 points higher than humans for both accuracy and comprehensiveness. CONCLUSIONS Paid versions of ChatGPT remain the highest quality and most versatile option of available LLMs. These tools cannot replace expert input but serve as powerful assistants, streamlining the development process and enhancing productivity. CLINICALTRIAL n/a
- 28 August 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessLeveraging Artificial Intelligence Large Language Models for Writing Clinical Trial Proposals in Dermatology (Preprint)
BACKGROUND Large language models (LLMs) are becoming increasingly popular in clinical trial design but have been underutilized in research proposal development. OBJECTIVE This study compares the performance of commonly used open access LLMs versus human proposal composition and review. METHODS Ten LLMs were prompted to write a research proposal. Six physicians and each of the LLMs assessed 11 blinded proposals for capabilities and limitations in accuracy and comprehensiveness. RESULTS Chat GPT o1 was rated the most accurate and LLaMA 3.1 the least accurate by human scorers. LLM scorers rated Chat GPT o1 and Deepseek R1 the most accurate. Chat GPT o1 was the most comprehensive and LLaMA 3.1 the least comprehensive by human and LLM scorers. LLMs performed poorly on scoring proposals, and on average rated proposals 1.9 points higher than humans for both accuracy and comprehensiveness. CONCLUSIONS Paid versions of ChatGPT remain the highest quality and most versatile option of available LLMs. These tools cannot replace expert input but serve as powerful assistants, streamlining the development process and enhancing productivity. CLINICALTRIAL n/a
- 6 December 2024
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 88, 274.e5-274.e7
From empiric anti-scabietic treatments to delusional infestation: A case report
- 6 December 2024
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 88, 274.e5-274.e7
From empiric anti-scabietic treatments to delusional infestation: A case report